Vistide (Cidofovir Injection) by Gilead: Recall - Presence Of Particulate Matter
Audience: Pharmacy, Patient, Health Professional ISSUE: Gilead Sciences, Inc. is voluntarily recalling lot B120217A of Vistide® (cidofovir injection) to the user level due to the presence of particulate matter found in some vials of this...
Source: Drugs.com - FDA MedWatch Alerts - Category: Drugs & Pharmacology Source Type: news
More News: Drugs & Pharmacology | Health